Friday, February 17th

Ander Urruticoechea, Onkologikoa, San Sebastián, Spain
16:00 - 16:20ESMO guidelines for breast cancer: how are they made?
Curigliano Giuseppe, European Institute of Oncology, Milan, Italy
16:20 - 16:40Adherence to oral breast cancer therapies
Iván Bustillos, Clínica Portoazul Auna, Barranquilla, Colombia
16:40 - 17:00De-escalation of antineoplastic therapies: Principles and considerations
Henk Van Halteren, Adrz-Admiraal de Ruijter Medical Center, Goes, Netherlands
17:00 - 17:30Discussion
José Enrique Alés, Centro de Patología de la Mama - Fundación Tejerina, Madrid, Spain
17:45 - 18:05What have we seen from oral SERDs and what could they mean for our patients in future?
Aditya Bardia, Massachusetts General Hospital Cancer Center, Boston, USA
18:05 - 18:25Safety management of Antibody-Drug-Conjugates
Maryam Lustberg, Yale University School of Medicine, New Haven, USA
18:25 - 18:45Managing brain metastases for HER2+ breast cancer
Diana Lüftner, Charité Campus Benjamin Franklin, Medizinische Klinik III, Berlin, Germany
18:45 - 19:15Discussion
Miguel Martín, Hospital General Universitario Gregorio Marañón, Madrid, Spain